195 related articles for article (PubMed ID: 31407032)
61. Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.
Tokiniwa H; Horiguchi J; Takata D; Kikuchi M; Rokutanda N; Nagaoka R; Sato A; Odawara H; Tozuka K; Oyama T; Takeyoshi I
Breast Cancer; 2012 Oct; 19(4):309-14. PubMed ID: 21725655
[TBL] [Abstract][Full Text] [Related]
62. [The value of Ki-67 antigen expression in tissue microarray method in prediction prognosis of patients with endometrioid endometrial cancer].
Gottwald L; Kubiak R; Sek P; Piekarski J; Szwalski J; Pasz-Walczak G; Spych M; Suzin J; Tylińskis W; Jeziorski A
Ginekol Pol; 2013 Jun; 84(6):444-9. PubMed ID: 24032262
[TBL] [Abstract][Full Text] [Related]
63. Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index.
Ono M; Tsuda H; Yoshida M; Shimizu C; Kinoshita T; Tamura K
Clin Breast Cancer; 2017 Feb; 17(1):41-47. PubMed ID: 27477822
[TBL] [Abstract][Full Text] [Related]
64. Long-term outcome of breast cancer patients with pathologic N3a lymph node stage.
Grassadonia A; Vici P; Gamucci T; Moscetti L; Pizzuti L; Mentuccia L; Iezzi L; Scognamiglio MT; Zilli M; Giampietro J; Graziano V; Natoli C; Tinari N
Breast; 2017 Apr; 32():79-86. PubMed ID: 28064072
[TBL] [Abstract][Full Text] [Related]
65. Prognostic value of vitamin D receptor and insulin-like growth factor receptor 1 expression in triple-negative breast cancer.
Soljic M; Mrklic I; Tomic S; Omrcen T; Sutalo N; Bevanda M; Vrdoljak E
J Clin Pathol; 2018 Jan; 71(1):34-39. PubMed ID: 28663327
[TBL] [Abstract][Full Text] [Related]
66. A prognostic model for triple-negative breast cancer patients based on node status, cathepsin-D and Ki-67 index.
Huang L; Liu Z; Chen S; Liu Y; Shao Z
PLoS One; 2013; 8(12):e83081. PubMed ID: 24340082
[TBL] [Abstract][Full Text] [Related]
67. HER3 status by immunohistochemistry is correlated with poor prognosis in hormone receptor-negative breast cancer patients.
Bae SY; La Choi Y; Kim S; Kim M; Kim J; Jung SP; Choi MY; Lee SK; Kil WH; Lee JE; Nam SJ
Breast Cancer Res Treat; 2013 Jun; 139(3):741-50. PubMed ID: 23722313
[TBL] [Abstract][Full Text] [Related]
68. Correlation between p53 and epidermal growth factor receptor expression in breast cancer classification.
Wang XZ; Liu Q; Sun JJ; Zuo WS; Hu DW; Ma SG; Mu DB; Yu ZY
Genet Mol Res; 2015 Apr; 14(2):4282-90. PubMed ID: 25966200
[TBL] [Abstract][Full Text] [Related]
69. Caveolin-1 expression as a prognostic marker in triple negative breast cancers of Asian women.
Yeong J; Thike AA; Ikeda M; Lim JCT; Lee B; Nakamura S; Iqbal J; Tan PH
J Clin Pathol; 2018 Feb; 71(2):161-167. PubMed ID: 28735300
[TBL] [Abstract][Full Text] [Related]
70. Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers.
Thike AA; Iqbal J; Cheok PY; Chong AP; Tse GM; Tan B; Tan P; Wong NS; Tan PH
Am J Surg Pathol; 2010 Jul; 34(7):956-64. PubMed ID: 20495445
[TBL] [Abstract][Full Text] [Related]
71. [Analysis of prognostic factors related to triple-negative breast cancer].
Shen SJ; Sun Q; Zhou YD; Guan JH; Mao F; Lin Y; Peng L; Xu Y; Wang XF; Xia W; Yao R; Han SM
Zhonghua Wai Ke Za Zhi; 2013 Nov; 51(11):1000-4. PubMed ID: 24444685
[TBL] [Abstract][Full Text] [Related]
72. Girdin protein expression is associated with poor prognosis in patients with invasive breast cancer.
Choi JS; Kim KH; Oh E; Shin YK; Seo J; Kim SH; Park S; Choi YL
Pathology; 2017 Oct; 49(6):618-626. PubMed ID: 28818465
[TBL] [Abstract][Full Text] [Related]
73. Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis.
Giudici F; Petracci E; Nanni O; Bottin C; Pinamonti M; Zanconati F; Scaggiante B
PLoS One; 2019; 14(6):e0218030. PubMed ID: 31220107
[TBL] [Abstract][Full Text] [Related]
74. Identification of patients with node-negative, triple-negative breast cancer who benefit from adjuvant cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy.
Wu CE; Chen SC; Lin YC; Lo YF; Hsueh S; Chang HK
Anticancer Res; 2014 Mar; 34(3):1301-6. PubMed ID: 24596377
[TBL] [Abstract][Full Text] [Related]
75. Calpain-1 Expression in Triple-Negative Breast Cancer: A Potential Prognostic Factor Independent of the Proliferative/Apoptotic Index.
Al-Bahlani SM; Al-Rashdi RM; Kumar S; Al-Sinawi SS; Al-Bahri MA; Shalaby AA
Biomed Res Int; 2017; 2017():9290425. PubMed ID: 28536704
[TBL] [Abstract][Full Text] [Related]
76. Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients.
Nagahashi M; Ling Y; Toshikawa C; Hayashida T; Kitagawa Y; Futamura M; Kuwayama T; Nakamura S; Yamauchi H; Yamauchi T; Kaneko K; Kanbayashi C; Sato N; Tsuchida J; Moro K; Nakajima M; Shimada Y; Ichikawa H; Lyle S; Miyoshi Y; Takabe K; Okuda S; Wakai T
Breast Cancer; 2023 Jul; 30(4):584-595. PubMed ID: 36930419
[TBL] [Abstract][Full Text] [Related]
77. Adipophilin expression is an independent marker for poor prognosis of patients with triple-negative breast cancer: An immunohistochemical study.
Yoshikawa K; Ishida M; Yanai H; Tsuta K; Sekimoto M; Sugie T
PLoS One; 2020; 15(11):e0242563. PubMed ID: 33201923
[TBL] [Abstract][Full Text] [Related]
78. KI-67 LI Expression in Triple-Negative Breast Cancer Patients and Its Significance.
Arafah MA; Ouban A; Ameer OZ; Quek KJ
Breast Cancer (Auckl); 2021; 15():11782234211016977. PubMed ID: 34158798
[TBL] [Abstract][Full Text] [Related]
79. Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis.
Wu Q; Ma G; Deng Y; Luo W; Zhao Y; Li W; Zhou Q
Front Oncol; 2019; 9():1068. PubMed ID: 31681601
[No Abstract] [Full Text] [Related]
80. Varying outcomes of triple-negative breast cancer in different age groups-prognostic value of clinical features and proliferation.
Vihervuori H; Korpinen K; Autere TA; Repo H; Talvinen K; Kronqvist P
Breast Cancer Res Treat; 2022 Dec; 196(3):471-482. PubMed ID: 36261751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
